JODY MAFFEI: Open Payments
NPI 1134707524 · BARNEGAT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 25 payments from 11 companies in 2025. Trend: 2023 $1,543 · 2024 $1,382 · 2025 $724
Food & beverage: $621Education: $103
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $169 |
| Journey Medical Corporation | 1 | $119 |
| UCB, Inc. | 1 | $99 |
| Galderma Laboratories, L.P. | 1 | $92 |
| E.R. Squibb & Sons, L.L.C. | 4 | $63 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| ABBVIE INC. | 3 | $49 |
| GENZYME CORPORATION | 2 | $32 |
| Incyte Corporation | 1 | $19 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $19 |
Products named: DUPIXENT, Bimzelx, NEMLUVIO, Sotyktu, Rhapsido, RINVOQ, OPZELURA, ADBRY.
Industry payments across NJ — which companies pay providers there.
